Major drivers of myeloid recruitment and heterogeneity in solid tumors
| . | Mutation . | Cancer cell secretory/gene expression profile . | Tumor . | Myeloid response . | Reference . |
|---|---|---|---|---|---|
| TP53 | TP53R175H | ↑ CXCL1, CXCL5, and CCL2 | PDAC | Activation NF-κB pathway Neutrophil and monocyte recruitment | Mahat et al. (2025) |
| Trp53−/− | ↑ CCL2 and CSF-1 | NSCLC and PDAC | Macrophage recruitment via CXCR3 | Blagih et al. (2020) | |
| Trp53−/− | ↑ CCL2, IL-1, IL-17A, and G-CSF | Breast tumors | Recruitment of immNeus | Wellenstein et al. (2019) | |
| PI3K | PI3KCAH1047R | ↑ Csf1, Ccl2, and Ccl7 | CRC | Enhanced recruitment of immunosuppressive myeloid cells. ↑ CCR2, arginase, and IL-1β expression | Collins et al. (2022) |
| PTEN | Pten-/- | ↑ Il1a and Il1r1 ↑ Ifit1, Tnfaip2, Cxcl2, Cxcl13, and Cxcl15 | PCa | Activation NF-κB pathway. Recruitment of neutrophils, monocytes, and macrophages | Jiang et al. (2025a) |
| KRAS | KRASG12D/KRASG12C | ↑ IL-1α/β, IL-6, TNFα, CXCL1/2/5/8, and CCL2 | PDAC, CRC, and NSCLC | NF-κB activation | Hamarsheh et al. (2020) |
| KrasG12D | ↓ TGFA, TGFB, CXCL1, and CXCL2 | NSCLC | Increased infiltration of F4/80 MPO+, complement genes, Mrc1, and Csf1r ↑ CCL2, IL-1β, and CCL4 | Lasse-Opsahl et al. (2025) | |
| GM-CSF and lactate | CRC | Reprogrammed TAMs IL-10+, TGF-β+, and CCL17+ | Liu et al. (2021) | ||
| LK1B | LKB1 loss | ↑ IL-6, IL-8, and CXCL1/8 | NSCLC | ↑ Neutrophil recruitment ↓ Type II–IFN signaling | Skoulidis and Heymach (2019), Li et al. (2021), Compton et al. (2023), and Koyama et al. (2016) |
| . | Mutation . | Cancer cell secretory/gene expression profile . | Tumor . | Myeloid response . | Reference . |
|---|---|---|---|---|---|
| TP53 | TP53R175H | ↑ CXCL1, CXCL5, and CCL2 | PDAC | Activation NF-κB pathway Neutrophil and monocyte recruitment | Mahat et al. (2025) |
| Trp53−/− | ↑ CCL2 and CSF-1 | NSCLC and PDAC | Macrophage recruitment via CXCR3 | Blagih et al. (2020) | |
| Trp53−/− | ↑ CCL2, IL-1, IL-17A, and G-CSF | Breast tumors | Recruitment of immNeus | Wellenstein et al. (2019) | |
| PI3K | PI3KCAH1047R | ↑ Csf1, Ccl2, and Ccl7 | CRC | Enhanced recruitment of immunosuppressive myeloid cells. ↑ CCR2, arginase, and IL-1β expression | Collins et al. (2022) |
| PTEN | Pten-/- | ↑ Il1a and Il1r1 ↑ Ifit1, Tnfaip2, Cxcl2, Cxcl13, and Cxcl15 | PCa | Activation NF-κB pathway. Recruitment of neutrophils, monocytes, and macrophages | Jiang et al. (2025a) |
| KRAS | KRASG12D/KRASG12C | ↑ IL-1α/β, IL-6, TNFα, CXCL1/2/5/8, and CCL2 | PDAC, CRC, and NSCLC | NF-κB activation | Hamarsheh et al. (2020) |
| KrasG12D | ↓ TGFA, TGFB, CXCL1, and CXCL2 | NSCLC | Increased infiltration of F4/80 MPO+, complement genes, Mrc1, and Csf1r ↑ CCL2, IL-1β, and CCL4 | Lasse-Opsahl et al. (2025) | |
| GM-CSF and lactate | CRC | Reprogrammed TAMs IL-10+, TGF-β+, and CCL17+ | Liu et al. (2021) | ||
| LK1B | LKB1 loss | ↑ IL-6, IL-8, and CXCL1/8 | NSCLC | ↑ Neutrophil recruitment ↓ Type II–IFN signaling | Skoulidis and Heymach (2019), Li et al. (2021), Compton et al. (2023), and Koyama et al. (2016) |